Sotera Health PE Ratio 2019-2025 | SHC
Current and historical p/e ratio for Sotera Health (SHC) from 2019 to 2025. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Sotera Health PE ratio as of July 22, 2025 is 18.32.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
Sotera Health PE Ratio Historical Data | |||
---|---|---|---|
Date | Stock Price | TTM Net EPS | PE Ratio |
2025-07-22 | 11.36 | 142.00 | |
2025-03-31 | 11.66 | $0.08 | 145.75 |
2024-12-31 | 13.68 | $0.15 | 91.20 |
2024-09-30 | 16.70 | $0.25 | 66.80 |
2024-06-30 | 11.87 | $0.14 | 84.79 |
2024-03-31 | 12.01 | $0.19 | 63.21 |
2023-12-31 | 16.85 | $0.18 | 93.61 |
2023-09-30 | 14.98 | $-1.10 | 0.00 |
2023-06-30 | 18.84 | $-0.96 | 0.00 |
2023-03-31 | 17.91 | $-0.93 | 0.00 |
2022-12-31 | 8.33 | $-0.83 | 0.00 |
2022-09-30 | 6.82 | $0.44 | 15.50 |
2022-06-30 | 19.59 | $0.45 | 43.53 |
2022-03-31 | 21.66 | $0.49 | 44.20 |
2021-12-31 | 23.55 | $0.42 | 56.07 |
2021-09-30 | 26.15 | $0.12 | 217.92 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Services | $3.225B | $1.100B |
Sotera Health Company is a provider of mission-critical end-to-end sterilization solutions and lab testing as well as advisory services for the healthcare industry. The company market through businesses which include Sterigenics(R), Nordion(R) and Nelson Labs(R). Sotera Health Company is Sotera Health Company is based in CLEVELAND. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Danaher (DHR) | United States | $135.913B | 25.22 |
CVS Health (CVS) | United States | $77.267B | 9.60 |
Elevance Health (ELV) | United States | $63.437B | 8.53 |
Cencora (COR) | United States | $56.784B | 19.75 |
DiDi Global (DIDIY) | China | $26.545B | 28.20 |
Labcorp Holdings (LH) | United States | $21.098B | 17.11 |
Natera (NTRA) | United States | $19.106B | 0.00 |
BioMerieux (BMXMF) | France | $15.985B | 0.00 |
EUROFINS SCIENT (ERFSF) | Luxembourg | $14.371B | 0.00 |
Medpace Holdings (MEDP) | United States | $13.731B | 35.52 |
CochLear (CHEOY) | Australia | $13.060B | 0.00 |
ICON (ICLR) | Ireland | $13.042B | 12.12 |
Solventum (SOLV) | United States | $12.616B | 13.35 |
Revvity (RVTY) | United States | $11.331B | 19.50 |
Viatris (VTRS) | United States | $10.845B | 3.73 |
Sonic Healthcare (SKHHY) | Australia | $8.965B | 0.00 |
Avantor (AVTR) | United States | $8.872B | 12.89 |
HealthEquity (HQY) | United States | $8.424B | 36.90 |
Charles River Laboratories (CRL) | United States | $8.024B | 15.72 |
Caris Life Sciences,�Inc (CAI) | United States | $7.706B | 0.00 |
Amplifon S.p.A (AMFPF) | Italy | $5.378B | 29.44 |
Bausch + Lomb (BLCO) | Canada | $5.059B | 29.79 |
BrightSpring Health Services (BTSG) | United States | $3.542B | 32.50 |
Surgery Partners (SGRY) | United States | $2.827B | 36.77 |
Organon (OGN) | United States | $2.553B | 2.71 |
Concentras Parent (CON) | United States | $2.534B | 14.64 |
Alignment Healthcare (ALHC) | United States | $2.441B | 0.00 |
GeneDx Holdings (WGS) | United States | $2.308B | 88.90 |
Progyny (PGNY) | United States | $1.970B | 43.36 |
GoodRx Holdings (GDRX) | United States | $1.757B | 35.14 |
PACS (PACS) | United States | $1.750B | 0.00 |
Premier (PINC) | United States | $1.738B | 13.19 |
Ardent Health (ARDT) | United States | $1.503B | 6.41 |
Teladoc Health (TDOC) | United States | $1.477B | 0.00 |
Establishment Labs Holdings (ESTA) | $1.257B | 0.00 | |
Pediatrix Medical (MD) | United States | $1.094B | 8.33 |
Ryman Healthcare (RYHTY) | New Zealand | $0.970B | 0.00 |
Agilon Health (AGL) | United States | $0.902B | 0.00 |
QDM (QDMI) | Hong Kong, SAR China | $0.846B | 290.00 |
AMN Healthcare Services Inc (AMN) | United States | $0.763B | 7.14 |
CareDx (CDNA) | United States | $0.725B | 11.32 |
Embecta (EMBC) | United States | $0.625B | 4.21 |
Nutex Health (NUTX) | United States | $0.556B | 8.41 |
So-Young (SY) | China | $0.541B | 0.00 |
InnovAge Holding (INNV) | United States | $0.524B | 0.00 |
SBC Medicals (SBC) | United States | $0.516B | 0.00 |
Omada Health (OMDA) | $0.495B | 0.00 | |
Auna S.A (AUNA) | Luxembourg | $0.471B | 10.62 |
LifeMD (LFMD) | United States | $0.471B | 0.00 |
Sonida Senior Living (SNDA) | United States | $0.468B | 0.00 |
COMPASS Pathways (CMPS) | United Kingdom | $0.414B | 0.00 |
Enhabit (EHAB) | United States | $0.342B | 28.17 |
Oncology Institute (TOI) | United States | $0.316B | 0.00 |
Performant Healthcare (PHLT) | United States | $0.287B | 0.00 |
Beauty Health (SKIN) | United States | $0.231B | 0.00 |
DocGo (DCGO) | United States | $0.149B | 24.33 |
Pheton Holdings (PTHL) | China | $0.148B | 0.00 |
Sera Prognostics (SERA) | United States | $0.109B | 0.00 |
Ascend Wellness Holdings (AAWH) | United States | $0.081B | 0.00 |
KindlyMD (NAKA) | United States | $0.067B | 0.00 |
NeueHealth (NEUE) | United States | $0.061B | 0.00 |
IceCure Medical (ICCM) | Israel | $0.058B | 0.00 |
Biodesix (BDSX) | United States | $0.053B | 0.00 |
NeuroOne Medical Technologies (NMTC) | United States | $0.051B | 0.00 |
ModivCare (MODV) | United States | $0.046B | 0.00 |
Basel Medical Group (BMGL) | Singapore | $0.041B | 0.00 |
OSR Holdings (OSRH) | United States | $0.020B | 0.00 |
Intelligent Bio Solutions (INBS) | United States | $0.016B | 0.00 |
Co-Diagnostics (CODX) | United States | $0.010B | 0.00 |
BioNexus Gene Lab (BGLC) | $0.009B | 0.00 | |
SeaStar Medical Holding (ICU) | United States | $0.009B | 0.00 |
XWELL (XWEL) | United States | $0.007B | 0.00 |
Aclarion (ACON) | United States | $0.004B | 0.00 |
ISpecimen (ISPC) | United States | $0.003B | 0.00 |
INVO Fertility (IVF) | United States | $0.002B | 0.00 |
NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
Cano Health (CANOQ) | United States | $0.000B | 0.00 |